The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Mon, 16.12.2024
UiPath
US90364P1057
UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that it has been positioned the highest in the Leader category in the inaugural Everest Group Intelligent Automation Platforms PEAK Matrix® Assessment 2024.
UiPath enables businesses to understand, optimize, and automate complex processes end-to-end, un...
UiPath, Inc. (NYSE: PATH), a leading enterprise automation and AI software company, today announced financial results for its third quarter fiscal 2025 ended October 31, 2024.
“Our customers’ response to the agentic automation vision and roadmap that we announced at FORWARD has been energizing and reinforces our leading position in the AI-powere...
UiPath, Inc. (NYSE: PATH), a leading enterprise automation and AI software company, today announced that Ashim Gupta, Chief Financial Officer and Chief Operating Officer, will participate in a fireside chat at the Barclays 22nd Annual Global Technology Conference, to be held at the Palace Hotel in San Francisco, CA on Wednesday, December 11th at 8...
UiPath, Inc. (NYSE: PATH), a leading enterprise automation and AI software company, today announced it will report financial results for its third quarter fiscal 2025 ended October 31, 2024 after the market closes on Thursday, December 5, 2024. Management will host a conference call and webcast to discuss the Company's financial results at 5:00 pm...
UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that it is transforming operations for Omega Healthcare, a global leader in revenue cycle management, healthcare and clinical enablement services, through AI-powered automation.
Omega Healthcare was named an UiPath AI25 Award Winner at UiPath FORWARD, Ui...
UiPath (NYSE: PATH), a leading enterprise automation and AI software company, announced today that Banco Azteca is transforming its operations and achieving significant efficiency gains with the strategic implementation of AI and automation from UiPath.
Banco Azteca is one of Mexico's largest financial institutions, and a subsidiary of Grupo Sali...
UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that La Française des Jeux (FDJ), France's top gaming operator, has successfully implemented the UiPath Platform to revolutionize key business processes through three innovative projects. This transformative initiative has also earned FDJ recognition as a...
UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced the winners of its UiPath AI25 Awards program. The annual program recognizes the 25 most innovative UiPath customers using AI and automation as a strategic change enabler to accelerate bigger and bolder business outcomes. The 25 winning organizations were...
UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced the integration of Anthropic's large language model (LLM), Claude 3.5 Sonnet, to deliver new AI features in three key products, including UiPath Autopilot for everyone, Clipboard AI, and a new medical record summarization solution. Businesses will be able...
UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced a strategic partnership with Inflection AI to integrate the UiPath Platform with the new Inflection for Enterprise solution, allowing enterprises to achieve greater levels of operational efficiency and effectiveness, without compromising trust and AI secu...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .